Kura Oncology launches diabetes-focused Caspian Therapeutics
Just under a year after netting its first US approval for a cancer-fighting menin inhibitor, Kura Oncology…
Amylyx endocrine drug succeeds in key study for low blood sugar
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
Enveda weight loss maintenance pill mimics exercise in early tests
If you could design an oral treatment that limits appetite and mimics some effects of physical activity, you…
From GLP-1 hormone to weight-loss drug: How semaglutide is made and why quality matters
What does it really take to recreate one of today’s most talked-about medicines? As semaglutide gains traction worldwide,…
Eli Lilly to offer retatrutide access given earlier to just one patient
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
The Startup Behind The Pill For Sleep Apnea Raises $192 Million In IPO
Apnimed CEO Kevin Lind Apnimed Even before it gets approval for its sleep apnea pill, Apnimed is testing…
The covalent drug arsenal gets a new warhead
A new platform that adds bicyclobutanes to amines could be used to create covalent drugs that have…
Compounded GLP-1s: Why doctors worry and the FDA is cracking down
So, are these copycat versions of the weight loss drugs safe? Poison control centers across the U.S. have…
Rare disease drugmakers seek exclusion from Medicare pricing plans
WASHINGTON — Biotech companies are lobbying the Trump administration to exclude treatments for rare diseases from programs that…
Revolution Medicines, Sanofi, Biogen, SSRIs: Readout Newsletter
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
Scientists’ Side Hustle? Using AI and Quantum Computing to Generate New Peptides
Scientists have successfully shown a quantum computer can improve the accuracy and reach of generative artificial intelligence drug…
Roche, Eli Lilly, Novo, gene therapy, Hansoh: Readout Newsletter
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…